Clinical role of lung clearance index in the assessment of cystic fibrosis lung disease
dc.contributor.advisor
Cunningham, Steve
dc.contributor.author
Armstrong, David K.
dc.date.accessioned
2023-02-01T17:39:23Z
dc.date.available
2023-02-01T17:39:23Z
dc.date.issued
2019-05-31
dc.description.abstract
[No Deposit Agreement]
en
dc.identifier.uri
https://hdl.handle.net/1842/39793
dc.identifier.uri
http://dx.doi.org/10.7488/era/3041
dc.language.iso
en
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Alton E, Armstrong DK, Ashby D, et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 2015;3(9):684-91.
en
dc.relation.hasversion
Armstrong DK et al. Gene therapy in cystic fibrosis. Arch Dis Child 2014;99(5):465-8.
en
dc.subject
lung clearance index
en
dc.subject
cystic fibrosis
en
dc.subject
lung disease
en
dc.subject
cystic fibrosis lung disease
en
dc.subject
Multiple Breath Washout
en
dc.subject
early small airways disease
en
dc.subject
SF6MBW derived LCI
en
dc.subject
CF lung disease
en
dc.title
Clinical role of lung clearance index in the assessment of cystic fibrosis lung disease
en
dc.title.alternative
The clinical role of lung clearance index in the assessment of cystic fibrosis lung disease
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
MD Doctor of Medicine
en
Files
Original bundle
1 - 1 of 1
- Name:
- ArmstrongDK_2019.pdf
- Size:
- 5.28 MB
- Format:
- Adobe Portable Document Format
- Description:
This item appears in the following Collection(s)